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Pantothenamides are analogs of pantothenic acid (vitamin B5), which is a natural precursor of coenzyme A
(CoA). It has been shown that these compounds, predominantly N-substituted pantothenamides, possess
antimicrobial activity against various pathogenic bacteria such as E. coli and S. aureus. It is widely accepted
that these compounds act through combined inhibition of coenzyme A and fatty acid synthesis. However,
the precise mechanism of action remains unrevealed. Here is reported the identiﬁcation of a novel target of
pantothenamides, never considered before. Molecular dynamics simulations together with free energy
calculations reveal that the hydrophobic pocket of the acyl carrier protein (ACP) binds N-
pentylpantothenamide. Consequently, the sequestration of the acyl chain attached to the Ppant
prosthetic arm is defunct since the inhibitor occupies the hydrophobic core of the ACP. Thus, the acyl
chain remains solvent-exposed and susceptible to hydrolysis. Moreover, the ACP with N-
pentylpantothenamide bound could change its chain-ﬂipping ability as well as its interaction propensity
towards downstream enzyme partners of the fatty acid synthesis pathway, which could result in the
suppression of the fatty acid synthesis rate.Introduction
The concept of anti-vitamins, inhibitors of metabolic processes
that involve a specic vitamin, was established in the early 1930s,
with the discovery of the sulfonamides. Since anti-vitamins
structurally resemble vitamins, they easily enter bacterial cells
through various transport systems. This idea led to the propulsive
search for new anti-vitamin compounds, which resulted in the
discovery of N-substituted pantothenamides, pantothenic acid
analogs. These analogs, in the rst place prototypic N-pentyl-
pantothenamide (N5-Pan) and N-heptylpantothenamide (N7-
Pan), are bacteriostatic compounds.1 Pantothenamides are also
shown to be potent inhibitors of the growth of the human
malaria parasite Plasmodium falciparum.2 However, the antimi-
crobialmode of action of the pantothenate antimetabolites is still
under debate. The accepted mechanism is shown in Fig. 1.
Pantothenate kinase (PanK), an enzyme of the coenzyme A
(CoA) biosynthetic pathway, utilizes N-pentylpantothenamide as
a substrate instead of pantothenate. The resulting compound
ethyldethia-CoA then inhibits the CoA-utilizing enzymes or
proteins.3 For instance, apo acyl carrier protein (apo-ACP), is post-
translationally modied with 40-phosphopantetheine (Ppant)
prosthetic group derived from CoA, resulting in a biologically
functional holo-ACP. However, in the presence of ethyldethia-ganic Chemistry and Biochemistry Group,
tia. E-mail: aleksandra.marsavelski@irb.
tion (ESI) available. See DOI:
95CoA, apo-ACP is modied with a dysfunctional prosthetic group
(Fig. 1), which leads to the accumulation of dysfunctional
ethyldethia-ACP (crypto-ACP).4 Moreover, in S. aureus, next to
ACP, pantothenamide antimetabolites are incorporated into
Dcp,5 which is a small carrier protein required for the transfer of
D-alanine to lipoteichoic acid in Gram-positive bacteria. Such
ethyldethia-ACP, deprived of the terminal thiol group, is no
longer capable of binding and delivering growing acyl chains to
the partner enzymes of the fatty acid biosynthesis pathway. Thus,
posttranslational modication of apo-ACP that results in
a dysfunctional prosthetic group, incapable of binding various
intermediates of the fatty acid synthesis, was seen as a bacterio-
static. Since the gene for the enzyme that hydrolyzes holo-ACP to
apo-ACP was unknown and, therefore, could not be expressed, it
was hypothesized that ACP phosphodiesterase was unable to
hydrolyze ethyldethia-ACP, a defective ACP. Consequently, it was
concluded that the ethyldethia-ACP accumulation leads to
bacterial cell death. A few years later, Thomas and Cronan have
shown that ACP phosphodiesterase is capable of hydrolyzing
ethyldethia-ACP both in vivo and in vitro, which ruled out the
accumulation of the ethyldethia-ACP as a cause of bacterial cell
death.6 Moreover, it was shown that in the presence of N5-Pan
neither overexpression of enzymes of the coenzyme A synthesis
pathway (PanK, CoaD, CoaE, and Dfp)6 nor supplementation of
the growth medium with pantothenate4 overcome the growth
inhibition. These results questioned the inhibition of CoA
synthesis, as a possible mechanism of action of pan-
tothenamides. Nevertheless, it was concluded that the mode of
action of pantothenamides is probably through the combinedThis journal is © The Royal Society of Chemistry 2016
Fig. 1 Schematic representation showing the mode of action of N-substituted pantothenamides through combined inhibition of the coenzyme
A and fatty acid synthesis. When N5-Pan is present in E. coli, PanK, an enzyme of the coenzyme A (CoA) biosynthetic pathway, utilizes the N5-Pan
instead of pantothenate. Resulting compound ethyldethia-CoA then inhibits the CoA-utilizing enzymes or proteins. For instance, acyl carrier
protein, a central player in the synthesis of all fatty acids, is post-translationally modiﬁed with a moiety derived from ethyldethia-CoA. Such
crypto-ACP is incapable of binding intermediates of the fatty acid synthesis pathway, causing the suppression of the fatty acid synthesis.
Table 1 Protein models used in molecular dynamics simulations
Model
Simulation time
per model
Number of independent
simulations
Apo-ACP 600 ns 1
Apo-ACP + N5-Pan 600 ns 3
Holo-ACP 600 ns 1
Holo-ACP + N5-Pan 600 ns 3
Hexanoyl-ACP 600 ns 1
Hexanoyl-ACP + N5-Pan 600 ns 3
Decanoyl-ACP 600 ns 1
Decanoyl-ACP + N5-Pan 600 ns 3
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View Article Onlineinhibition of the coenzyme A and fatty acid synthesis (Fig. 1),
leaving the precise mechanism unexplained.
Puzzled by ambiguous experimental data and intrigued by the
structural similarities between (a) N-substituted pan-
tothenamides and (b) saturated acyl chain covalently linked to 40-
phosphopantetheine (Ppant) prosthetic group, an alternative
cellular target for the pantothenamides is considered. In the
study reported here, the author was interested in whether the
hydrophobic core of the acyl carrier protein could be a target for
N-substituted pantothenamides. Moreover, if this proves to be
true, what are the potential consequences of the binding? Clas-
sical unbiasedmolecular dynamics simulations together with the
binding free energy calculations of N-pentylpantothenamide
bound inside the hydrophobic core of various forms of E. coli acyl
carrier proteins were performed to address these questions.
Materials and methods
Model preparation
Acyl carrier protein takes a central part in the fatty acid
synthesis. Fatty acids are synthesized in the repetitive cycle
consisting of the following reactions: condensation, reduction,
dehydration, and reduction. All of the intermediates are prod-
ucts of each of these reaction steps, and all of them are attached
to the Ppant prosthetic group of the holo-ACP that serves as
a carrier of a growing acyl chain. Thus, ACP operates by
exposing and shielding its cargo from the solvent and non-
partner enzyme for one particular step in the synthesis.
Substrate delivery demands the rst three carbon atoms of the
acyl intermediate to be exposed from the hydrophobic pocket of
the ACP in order to reach the catalytic residues of the corre-
sponding FAS enzyme. The reactions are repeated until, for
instance, the palmitoyl product (fully saturated C16 product) is
synthesized. NMR structural analysis7 revealed that ACP adopts
a unique conformation for each intermediate attached. Some of
these intermediates are 3-oxoacyl-[acyl-carrier-protein], 3-
hydroxyacyl-[acyl-carrier-protein], 2-trans-enoyl-[acyl-carrier-
protein], and fully saturated acyl-ACP, and all of them could
be placed in the hydrophobic pocket and exposed to the cor-
responding partner enzyme when necessary. Up to the present
time, molecular dynamics simulations are published for apo-,
holo-, and saturated acyl-forms of E. coli ACP,8 and forThis journal is © The Royal Society of Chemistry 2016intermediates in the fatty acid synthesis, 3-oxoacyl-[acyl-carrier-
protein], 3-hydroxyacyl-[acyl-carrier-protein] and 2-trans-enoyl-
[acyl-carrier-protein] of E. coli.9 Moreover, all of them captured
the transition from the solvent-exposed conformation to the
solvent shielded, which is, to date, well-known fact, studied
either experimentally or computationally. However, all of them
failed to show reverse motion, the extrusion from the hydro-
phobic pocket of the ACP. The reason lies in the fact that the
exposure of the acyl chain would never happen per se. In other
words, acyl carrier protein will never expose, by itself, acyl chain
attached to its prosthetic group to a solvent. To do so, ACP
requires a suitable protein partner with whom it can accom-
plish appropriate protein–protein contacts to fulll its biolog-
ical purpose, which is exposing and subsequent delivery of the
acyl chain to the active site of the partner enzyme.
In this regard, eight protein structures of the acyl carrier
protein are modeled (Table 1).
Starting structures of apo-ACP, an inactive acyl carrier
protein without the prosthetic group, and apo-ACP with N5-Pan
bound in the pocket are shown in Fig. 2A and B, respectively.
Starting structures of holo-ACP, hexanoyl-ACP, and decanoyl-
ACP with the solvent-exposed prosthetic arm as well as acyl
chains attached to it are shown in Fig. 2C, E and G. Holo-ACP +
N5-Pan, hexanoyl-ACP + N5-Pan, and decanoyl-ACP + N5-Pan
are ACPs with the solvent-exposed prosthetic groups with
simultaneously bound N5-Pan in the hydrophobic core of the
ACPs (Fig. 2D, F and H). Apo-ACP was modeled using the X-ray
structure of E. coli apo-ACP10 (ID 1T8K, 1.10 A˚). The crystalRSC Adv., 2016, 6, 44888–44895 | 44889
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View Article Onlinestructure of E. coli hexanoyl-ACP11 (ID 2FAC, 1.76 A˚) was used to
model manually N5-Pan accommodated in the hydrophobic
core from the buried hexanoyl chain. This structure was later
used to model apo-ACP + N5-Pan, holo-ACP + N5-Pan, hexanoyl-
ACP + N5-Pan, and decanoyl-ACP + N5-Pan, by overlapping
empty ACPs with ACP occupied with the N5-Pan and trans-
ferring the N5-Pan coordinates. ACPs with the solvent-exposed
prosthetic group (Ppant), and both hexanoyl- and decanoyl-
chains linked to the prosthetic group, were modeled based on
the crystal structure of the crosslinked E. coli ACP–FabA
complex12 (4KEH, 1.9 A˚). The coordinates of FabA enzyme from
the 4KEH crystal structure were deleted, while the coordinates
of the ACP with 40-phosphopantetheine group with the
sulphonyl-3-alkyne-based probe linked to it, which resemblesFig. 2 Starting structures for MD simulations. (A) Apo-ACP, acyl carrier
protein lacking its prosthetic group. (B) Apo-ACP in complex with N5-
Pan. (C) Holo-ACP, acyl carrier protein with the solvent-exposed pros-
thetic group. (D) Holo-ACP, acyl carrier protein with the solvent-
exposed prosthetic group, and simultaneously bound N5-Pan. (E)
Hexanoyl-ACP, acyl carrier protein with the solvent-exposed hexanoyl
acyl chain linked to the prosthetic group. (F) Hexanoyl-ACP, acyl carrier
protein with the solvent-exposed hexanoyl acyl chain linked to the
prosthetic group, and simultaneously boundN5-Pan in the hydrophobic
pocket of the ACP. (G) Decanoyl-ACP, acyl carrier protein with the
solvent-exposed decanoyl acyl chain linked to the prosthetic group. (H)
Decanoyl-ACP, acyl carrier protein with the solvent-exposed decanoyl
acyl chain linked to the prosthetic group, and simultaneously boundN5-
Pan in the hydrophobic pocket of the ACP.
44890 | RSC Adv., 2016, 6, 44888–44895decanoyl moiety, were retained. The cross-linking probe was
modied manually to decanoyl- and hexanoyl-acyl moieties. By
deleting sulphonyl-3-alkyne-based probe, the solvent exposed
40-phosphopantetheine (Ppant) was modeled. In this way, the
prosthetic group as well as acyl moieties pointed vertically up
from the ACP were obtained, thus imitating situation when the
Ppant + acyl chain is bound to one of the bacterial fatty acid
synthase II enzymes.Molecular dynamics simulation
All MD simulations were performed with the AMBER ﬀ12SB
force eld and the general AMBER force eld GAFF.13 Partial
charges for nonstandard residues (40-phosphopantetheine,
decanoyl-, hexanoyl-acyl moieties, and N5-Pan) were derived
using the RESP approach14 with charges calculated based on an
RESP t to an HF/6-31G* electrostatic potential. All protein
structures were solvated in a truncated octahedral box of TIP3P
water,15 such that no solute atom was less than 10 A˚ from box
edges. Na+ ions were added for neutralization. The monovalent
ion parameters16 for TIP3P water implemented in AMBER were
used. The resulting solvated system was energy-minimized in 3
cycles. In the rst cycle, proteins were xed using a restraint on
each protein atom while water, ions, and N5-Pan were allowed
to move using 500 steps of steepest descent minimization, fol-
lowed by 1000 steps of conjugate gradient minimization. In the
second cycle, proteins were xed using a restraint on backbone
atoms only while side chains of the protein, water, ions and N5-
Pan were allowed to move using 500 steps of steepest descent
minimization, followed by 2000 steps of conjugate gradient
minimization. In the last cycle, the whole system was energy-
minimized for 5000 steps, including 1500 steps of steepest
descent minimization and 3500 steps of conjugate gradient
minimization. Optimized systems were gradually heated from
0 to 300 K and equilibrated during 50 ps using NVT conditions,
and subjected to productive, unconstrained MD simulations at
constant pressure (1 atm) and temperature (300 K) using the
Berendsen barostat17 and Langevin thermostat,18 respectively.
The production runs, each 600 ns in length, were performed on
the GPU (NVIDIA Tesla M2075) using the pmemd.CUDA19–21
engine of AMBER12.22 Bonds involving hydrogen atoms were
constrained using the SHAKE algorithm.23 The time step was 2
fs. The Particle Mesh Ewald method24 was applied to calculate
long-range electrostatic interactions. Nonbonded interactions
were truncated at 10.0 A˚. For all protein complexes, three
independent MD simulations starting from the same initial
structure, but with diﬀerent random number seeds for initial
velocity assignment were performed. Therefore, three inde-
pendent 600 ns MD simulations for each complex were run,
giving a sum of 1.8 ms of total MD simulations for each complex
and a total of 7.2 ms across all four complexes. In this way, by
performing extensive MD simulations in triplicates for each
complex, the author wanted to check the convergence of the
simulations as well as the relevance and reliability of the
simulations and calculated binding free energies. This
approach is chosen because it provides the more eﬃcient
sampling of the conformational space since the complexes ofThis journal is © The Royal Society of Chemistry 2016
Fig. 3 Hexanoyl-ACP did not sequester its acyl chain in the hydro-
phobic pocket occupied with N5-Pan shown in cyan (left); decanoyl-
ACP did sequester its acyl chain in the hydrophobic pocket while N5-
Pan has been simultaneously pushed out (right).
Paper RSC Advances
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
3 
M
ay
 2
01
6.
 D
ow
nl
oa
de
d 
on
 0
6/
04
/2
01
7 
09
:2
2:
39
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article OnlineACP have been manually prepared, where a possibility of
imposed stability is higher.
Free energy calculations
The binding free energy of N5-Pan in apo-ACP + N5-Pan, holo-
ACP + N5-Pan, hexanoyl-ACP + N5-Pan and deacnoyl-ACP +
N5-Pan complexes, DGbind, was calculated according to the
following equation:
DGbind ¼ hGcomplexi  hGacyl carrier proteini  hGN5-PANi (1)
where the symbol hi represents the average value over 100 and
250 snapshots collected from the last 5 ns along each MD
trajectory. The free energy of a system can be approximated by
three terms:
Gcomplex/acyl carrier protein/N5-PAN ¼ EMM + Gsolv  TDSMM (2)
where EMM, the gas-phase molecular mechanical energy, is
calculated as the sum of Einternal, EvdW, and Eelec contributions.
Gsolv, the solvation free energy is the sum of polar (Gpolar) and
nonpolar (Gnonpolar) components, where the former was calcu-
lated by solving the Poisson–Boltzmann equation, while the
latter was determined on the basis of the solvent accessible
surface area (SASA) using the following equation:
Gnonpolar ¼ gSASA + b (3)
with empirical parameters set to g ¼ 0.0054 kcal mol1 A˚2 and
b ¼ 0.92 kcal mol1.25,26 The interior dielectric constant was set
to 1 while the exterior dielectric constant was set to 80. The
solute conformational entropy (SMM) was estimated by the
normal mode analysis based on 20 frames. Free energy calcu-
lations were performed using the MMPBSA.py,27 provided in
AmberTools15.28
Data analysis
All MD trajectories were analyzed using the CPPTRAJ29 available
in the AmberTools15. Cluster analysis was performed using
DBscan30 clustering method where the coordinate RMSD was
used as the distance metric. DBscan clustering was performed
on a subset of the protein backbone atoms. A distance cutoﬀ 3 of
0.9 A˚ between clusters was used and a minimum of 25 points
was required to form a cluster. VMD,31 Pymol32 soware as well
as Chimera,33 were employed for the protein and trajectory
visualization, where the last was used for making protein
movies. Graphs were plotted using Xmgrace34 and Gnuplot.35
The GNU Image Manipulation Program (GIMP, http://
www.gimp.org/) was used for gure preparation.
Results and discussion
Root-mean-square deviations (RMSD) of the uncomplexed ACPs
and ACPs in complex with N5-Pan throughout the simulation
period showed no signicant changes in the backbone of the
proteins, implying that the binding of N5-Pan in the hydro-
phobic core of the ACP does not aﬀect the protein stabilityThis journal is © The Royal Society of Chemistry 2016(Fig. S1†). All simulated ACPs complexes retained the N5-Pan in
the hydrophobic core of the ACP during the simulated period,
except for decanoyl-ACP + N5-Pan complexes, where the dec-
anoyl chain has pushed out the N5-Pan from the pocket in two
simulations out of three, while in the third simulation, N5-Pan
stayed bound during the entire simulation period. The holo-
ACP + N5-Pan complexes were stable during the simulated
period; i.e. N5-Pan remained bound in the hydrophobic core of
the ACPs (Fig. S2†). The same behavior is observed for the apo-
ACP + N5-Pan complexes (Fig. S3†). Moreover, both acyl-bearing
ACPs (hexanoyl- and decanoyl-ACP) exhibit the transition from
the solvent-exposed to the solvent-shielded acyl chains, which is
an inherent feature of class II acyl-bearing ACPs (Fig. S4 and S5,
and Movies S1 and S2†). On the other hand, the hexanoyl-ACP +
N5-Pan complexes did not show the transition of hexanoyl
chain in the hydrophobic core (Fig. 3 and S6, and Movie S3†).
Interestingly, in two simulations out of three, decanoyl-ACP +
N5-Pan did accommodate decanoyl chain in the hydrophobic
core while N5-Pan has been simultaneously pushed out (Fig. 3,
S7, and Movie S4†), while in the third simulation of the
decanoyl-ACP + N5-Pan complex, N5-Pan stayed bound during
the entire simulation period, i.e. ACP has not accommodated its
decanoyl chain in the hydrophobic pocket (Movie S5†).
All three simulations of the hexanoyl-ACP in complex with
N5-Pan failed to show the transition from the solvent-exposed
acyl chain to the solvent-shielded conformation. It seems that
hexanoyl chain could not compete in terms of hydrophobicity
with N5-Pan thus failed to enter into the hydrophobic core
(Movie S3†), which is not the case with decanoyl chain whose
hydrophobic character prevails over that of the N5-Pan, which
has been pushed out of the hydrophobic core in two out of three
simulations (Movie S4†).
N5-Pan binding to the acyl carrier protein did not inuence
the overall fold consisting of four a helices. Secondary structure
elements of ACPs are well preserved upon inhibitor binding
during all MD simulations (Fig. S8†). The binding free energies
were calculated for all complexes where N5-Pan stayed bound
during the entire simulation period of 600 ns. The calculated
binding free energies across 100 frames shown in Table 2 and
250 frames (Table S1†) indicate that the N5-Pan binding in theRSC Adv., 2016, 6, 44888–44895 | 44891
Table 2 Calculated binding free energies (DGbind) and their components
a obtained by the MM–PBSA method. 100 frames from the last 5 ns of
the MD trajectories were used. All values are in kcal mol1. Values in parentheses represent the standard deviation. Nmode analysis was per-
formed on 20 frames
System VDW EEL EPB ENPOLAR DHgas DHsolv DHbind TDS DGbind
Apo-ACP 32.1 27.3 36.7 4.6 59.4 32.1 27.3 (3.3) 21.4 (3.4) 5.9
Apo-ACP 33.4 27.4 40.0 4.8 60.8 35.2 25.6 (4.1) 20.9 (4.3) 4.7
Apo-ACP 29.7 35.4 43.5 4.7 65.1 38.8 26.3 (2.8) 21.0 (4.8) 5.3
Holo-ACP 32.1 30.2 40.5 4.6 62.3 35.9 26.4 (4.4) 20.9 (5.2) 5.5
Holo-ACP 37.4 21.1 38.8 4.9 58.5 33.9 24.6 (4.5) 19.4 (4.9) 5.2
Holo-ACP 30.2 35.2 44.1 4.5 65.4 39.6 25.9 (3.8) 20.1 (5.1) 5.8
Hexanoyl-ACP 32.4 36.5 46.4 4.7 68.9 41.7 27.2 (4.1) 22.8 (3.4) 4.4
Hexanoyl-ACP 37.2 34.4 47.4 4.7 71.6 42.7 28.9 (3.4) 23.4 (3.7) 5.5
Hexanoyl-ACP 32.0 28.5 39.0 4.6 60.5 34.4 26.1 (4.0) 21.6 (3.7) 4.5
Decanoyl-ACP 36.7 20.8 33.2 4.6 57.5 28.6 28.9 (3.7) 23.1 (3.2) 5.8
a VDW¼ van der Waals contribution fromMM; EEL¼ electrostatic energy as calculated by the MM force eld; EPB¼ the electrostatic contribution
to the solvation free energy calculated by PB; ENPOLAR ¼ nonpolar contribution to the solvation free energy calculated by an empirical model.
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View Article Onlinehydrophobic pockets of apo-, holo-, hexanoyl- and decanoyl-
ACPs is energetically favorable. Estimated binding free ener-
gies cluster around a value of 5 kcal mol1.
The most dominant contribution comes from the nonpolar
part (vdW + ENPOLAR), which prevails over the combined elec-
trostatic contribution (EEL + EPB). This favorable nonpolar
contribution can be rationalized as depicted in Fig. 4, which is
the representative structure of themost populated cluster derived
from the apoACP + N5-Pan trajectory. Clustering was performed
independently for each apoACP + N5-Pan complex, as described
in Data analysis section, giving a total of three representative
structures from the most populated clusters derived from three
trajectories. The three structures show a considerable overlap;
the backbone RMSD values between the rst and second, and the
rst and third representative structures from the most populated
clusters are 1.10 and 1.01 A˚, respectively.Fig. 4 Hydrophobic pocket of the ACP with N5-Pan bound showing
favorable hydrophobic interactions between the pentyl moiety of the
N5-Pan and amino acids of the hydrophobic pocket.
44892 | RSC Adv., 2016, 6, 44888–44895The pentyl moiety of the N5-Pan makes hydrophobic
contacts with the aromatic and nonpolar amino acids of the
hydrophobic pocket of the ACP, namely Phe28, Val29, Leu42,
Val43, Leu46, Ile54, Ala59, Ile62, Ala68. Next to favourable
hydrophobic contacts formed between pentyl moiety of the N5-
Pan and amino acids of the hydrophobic pocket, N-pentylpan-
tothenamide makes hydrogen bonds occasionally with the side-
chain hydroxyl group of Thr39, side-chain carboxyl group of
Glu60 (Fig. 4) and carbonyl oxygens of the peptide bond of
Ala59, Glu60 and Ile62 (Tables S2–S5 and Fig. S9†). As seen from
the interaction analysis performed on all ACPs complexes, N5-
Pan makes diﬀerent hydrogen bonding patterns with the resi-
dues of the hydrophobic core of the ACP within the same group
of simulated complexes, which implies that the sampling eﬃ-
ciency is signicantly augmented by performing three inde-
pendent simulations for the same complex. All simulated
proteins equally favour the binding of the N5-Pan, since the
calculated binding free energies are comparable to each other
(Tables 2 and S1†). Still, this trend does not allow to conclude
on the convergence of the calculations, but rather it corrobo-
rates the possibility of N5-Pan binding, and hence its inhibitory
capacity.
Given that the hydrophobic core is occupied with N5-Pan,
ACP does not show the sequestration of short-chain acyl
moieties, which stay longer exposed to the solvent, and conse-
quently more accessible to hydrolysis. For this type of inhibi-
tion, the following term is suggested: the stuﬀed pepper-like
inhibition of the chain-ipping mechanism. A proposed name
reects the situation where there is no more room le to
accommodate the acyl chain in the hydrophobic core of the ACP
aer N5-Pan is being bound (Fig. 5).
Biological implications
ACP is certainly one of the most important protein–protein
interaction hubs within the cell since is engaged in interactions
with more than a dozen enzymes of the fatty acid synthase
complex. A possible consequence of the N5-Pan binding in the
hydrophobic core of the ACP could be the altered protein–
protein interaction propensity towards the partner enzymes.This journal is © The Royal Society of Chemistry 2016
Fig. 5 A schematic representation showing the proposed stuﬀed
pepper-like inhibition of the chain-ﬂipping mechanism. The hexanoyl
chain is not shown for clarity.
Paper RSC Advances
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
3 
M
ay
 2
01
6.
 D
ow
nl
oa
de
d 
on
 0
6/
04
/2
01
7 
09
:2
2:
39
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article OnlineThis could be evident in the inability of the ACP to shuttle its
cargo properly from one enzyme to the next one in the fatty acid
biosynthesis pathway. However, the question of protein–protein
interactions between various forms of ACP in complex with N5-
Pan and partner enzymes of the FAS II should be addressed
experimentally. Since the mammalian FAS I system possesses
large macromolecular multidomain architecture36,37 while
microbial FAS II is built up of separate proteins, any drug that
would address separate enzymes of the bacterial type FAS I
would not interfere with the protein domains of the mamma-
lian FAS II. Considering architectural diﬀerences mentioned
above, there has been a continuous eﬀort in characterizing
enzymes of microbial FAS, as well as novel compounds targeting
them. Many compounds addressing the bacterial FAS enzymes
have already been discovered.38 However, diversity in the
enzymes and regulation of fatty acid synthesis in bacteria is
enormous that we could point out a single organism that we
could consider as a representative of bacteria as a whole or
study as a model system for the fatty acid synthesis inhibition.
Thus, the acyl carrier protein, central to fatty acid synthesis,
which is omnipresent,39,40 and moreover, structurally and
functionally conserved protein in bacteria, could be seen as
a promising target through which we could control microbial
viability. The hydrophobic pocket of microbial ACP could be
a promising target for novel antibiotics, which structurally
resembles the naturally sequestered intermediates of the fatty
acid biosynthesis pathway. One should bear in mind that at the
moment when E. coli cells are exposed to N5-Pan, E. coli pro-
teome consists of various forms of acyl carrier proteins i.e. apo-
CP, holo-CP and a variety of acyl-CP intermediates (3-oxoacyl-
[acyl-carrier-protein], 3-hydroxyacyl-[acyl-carrier-protein], 2-
trans-enoyl-[acyl-carrier-protein] and nal saturated acyl-forms
of ACP), since the fatty acid synthesis always operates in the
viable cell. In this regard, N5-Pan could be seen as a potent
inhibitor since it ts many protein targets that diﬀer only
slightly in the form of the prosthetic group and intermediate
attached to it. Inhibitory potential of the N5-Pan could be
realized through the additive eﬀect since it addresses more than
one target. Thus, any structural analog of 40-phosphopante-
theine prosthetic group with attached intermediate of the fattyThis journal is © The Royal Society of Chemistry 2016acid synthesis pathway could be a potent inhibitor of the chain-
ipping mechanism. In this way, the proper acyl chain
sequestration as well as protein–protein communication, both
essential in the fatty acid synthesis, could be defunct. However,
aer the discovery of N-alkylpantothenamides, structural
modication of these compounds was directed towards the
active site of PanK, an enzyme of the coenzyme A biosynthetic
pathway, of E. coli,41 S. aureus42,43 and P. falciparum44–46 in search
of more potent inhibitors. The model of pantothenamide-
induced inhibition of the bacterial growth proposed here
questions this strategy of the N5-Pan structural modication
directed exclusively towards the PanK active site and opens the
possibility of a novel cellular target to be taken into account.
The following experimental results published earlier
corroborate the N5-Pan mode of action presented here. The
pantothenate (a natural precursor for CoA biosynthesis) was
added to the growth medium to test whether it would diminish
the inhibitory eﬀect of the N5-Pan on the bacterial growth.4 The
addition of pantothenate to the growth medium did not
diminish the inhibitory eﬀect of the N5-Pan. Furthermore,
overexpression of E. coli gene for PanK, pantothenate kinase,
which catalyzes the rst and regulatory step in CoA biosyn-
thesis, failed to attenuate the inhibitory eﬀect of the N5-Pan.4
These results indicate that N5-Pan does not inhibit the CoA
biosynthetic pathway. Moreover, E. coli treated with the pan-
tothenamides are incapable of incorporating [1-14C]-acetate to
its membrane lipids, meaning that the fatty acid synthesis is
inhibited.4 The supplementation of the growth medium with
oleate failed to reverse growth inhibition by N5-Pan in E. coli
strain ANS1. However, this was explained by the fact that the
essential b-hydroxymyristic acid for lipid A synthesis in E. coli
can not be provided from the growth medium.4 Therefore,
a subsequent experiment selected the Gram-positive S. pneu-
moniae strain R6 against which N5-Pan was as eﬀective as
against E. coli strain. The addition of oleate to the growth
medium increased the minimum inhibitory concentration
(MIC) value by 4-fold, but was insuﬃcient to restore full
growth.4 Moreover, the addition of oleate and palmitate to the
growth medium of S. aureus treated with pantothenamide, only
allowed for the partial recovery of the bacterial growth.5 All
these results and conclusions clearly indicate that the fatty acid
synthesis is inhibited in the presence of the N5-Pan. Moreover,
the growth curves indicated delayed toxicity of pan-
tothenamides, showing a beginning of the slowdown in the
growth of the bacterial culture during the third doubling period
aer the addition of the inhibitor. Interestingly, the authors
themselves plainly pointed out:4 “The delayed toxicity of the
pantothenamides suggested that the mechanism of the antibacterial
activity required their incorporation into a cellular component
rather than the direct inhibition of an essential enzyme for bacterial
growth”.
Conclusions
In this study, widely employed in silico methods were used to
test simple ideas, which have not been investigated earlier. Here
is reported a new type of inhibition of microbial fatty acidRSC Adv., 2016, 6, 44888–44895 | 44893
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View Article Onlinesynthesis that could serve as a completely new strategy for the
design of novel antibiotics. It is demonstrated that acyl carrier
protein can bind the prototypic N-pentylpantothenamide in the
hydrophobic core, adopting the overall stuﬀed pepper look. As
a result, the ACP with intercalated pantothenamide displays
altered ability to sequester acyl chain in the hydrophobic core
since it is occupied with N-pentylpantothenamide. Thus, acyl
chain remains solvent-exposed on a longer time scale and
susceptible to hydrolysis. Moreover, the ACP in complex with
pantothenamide could change its chain-ipping mechanism
for delivering acyl moiety to the downstream partner enzymes of
the fatty acid synthesis pathway, which could lead to the
decreased rates of fatty acid synthesis. Results presented here
are in line with all previously published data and provide the
missing link in the understanding of ambiguous experimental
data,3–5 which to date have not explained how N5-Pan inhibits
the growth of E. coli. From the published studies3–5 is known
that N5-Pan is a substrate for PanK (a competitive inhibitor of
PanK), and thus instead of CoA at the end of the CoA metabolic
pathway, ethyldethia-CoA antimetabolite is being produced in
the presence of N5-Pan.3 On the other hand, in E. coli, four
genes, panB, panC, panD, and panE, encode four enzymes
required for de novo pantothenic acid (physiological substrate
for PanK) biosynthesis, which means that E. coli can overcome
the inhibition of the CoA biosynthetic pathway eventually
inhibited by the N5-Pan. Furthermore, the observed inhibition
of fatty acid synthesis in the presence of N5-Pan was explained
in the following way: ethyldethia-CoA metabolite was used as
a substrate for the post-translational modication of ACP,
which resulted in inactive ethyldethia-ACP incapable of deliv-
ering of a growing acyl chain in the fatty acid synthesis
pathway.4 However, a subsequent study has shown that the
ethyldethia-ACP is hydrolyzed in vivo,5 which means that E. coli
can renew its apo-ACP pool which can be eventually used again
for proper post-translational modication with amoiety derived
from CoA. In addition to the rapid turnover, ACP is expressed
constitutively in a cell. In other words, a physiologically active
form of the ACP is always present in a cell. Thus, the inhibition
of the bacterial growth is le unexplained. Therefore, the aim of
this study was to investigate, bearing in mind the structural
similarity between (a) the Ppant with attached acyl chain and (b)
the N5-Pan, whether the N5-Pan could occupy the hydrophobic
pocket of ACP, which naturally belongs to the Ppant prosthetic
group with acyl chain attached to it.
The proposed model of pantothenamide-induced inhibition
of the bacterial growth raises many questions as to whether the
structural modication of N-alkylpantothenamides should go
in the direction of the optimal accommodation in the hydro-
phobic core of the ACP? Could we modify the N-pan-
tothenamide structure in a way that we could obtain a tool for
studying the chain-ipping mechanism as well? Moreover, how
acyl carrier protein in complex with N5-Pan changes its inter-
action propensity towards the partner enzymes of the fatty acid
biosynthesis pathway? Although the author has experience in
working with similar proteins, and the previous results have
already been experimentally conrmed and have been in line
with experiments,47,48 unfortunately, computational methods44894 | RSC Adv., 2016, 6, 44888–44895alone are not suﬃcient and do not provide all answers to the
questions that have been raised here. Therefore, the author is
looking forward to passing the baton to experimental (bio)
chemists in hopes of creating game-changing opportunities
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